About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06122285

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

Multicenter pharmacological observational prospective, no-profit, study. This study was designed to get a "real-life" snapshot across several Italian Hepatology centers. All HDV patients are followed...

Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years of age or older
•Chronic hepatitis delta
•Compensated cirrhosis HDV related
•Patients who will start therapy with BLV 2 mg/day from May 2023

Exclusion Criteria

•HDV-related decompensated cirrhosis (CPT ≥7)

Related studies

DELTA DESCRIBE: the French Collaborative Project

NCT05936073 · Hepatitis D

HDV Screening Study

NCT06889805 · Hepatitis D Virus Infection

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

NCT04166266 · Hepatitis D, Chronic, Hepatitis B, Chronic

Standardising Care for Hepatitis Delta in the Netherlands

NCT05903742 · Hepatitis D

Active Not RecruitingNA

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

NCT06603311 · Compensated Liver Disease (Disorder), Hepatitis D, Chronic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 10, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateMay 2023

Last updatedJan 10, 2025

Condition

Locations shown

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy.

Milan, MI

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions